List your practice on InjuredCare | Log in / Sign up

Cancer Related to Blood Pressure Medications

Cancer Related to Blood Pressure Medications

Blood pressure is an essential element of personal health. You need enough pressure to ensure that your tissue and organs get the blood they need to keep them strong and alive. However, too much pressure can be a serious problem, damaging organs and putting you at risk of a stroke, heart attack, kidney failure or loss of vision.

Blood pressure medications come in a number of different forms:

  • ACE (angiotensin converting enzyme) inhibitors—This drug prevents the body from producing a substance that tightens your blood vessels, relaxing the vessels and lowering the pressure.
  • Beta-blockers—A beta-blocker slows down your heartbeat and lessens the strength of each beat, so that your blood is pumped through your veins with less force.
  • Diuretics—A diuretic increases the amount of urine you produce. When you eliminate more urine, you get rid of salt and water, decreasing the volume and pressure of your blood.
  • Calcium channel blockers—This medication decreases the speed and strength of your heartbeats, and relaxes the muscles around your blood vessels.
  • Angiotensin II receptor blockers—This drug works much like an ACE inhibitor, but instead of blocking the production of the substance that tightens veins, it prevents that substance from having any effect on your blood vessels.

Some studies have found a correlation between the use of ACE inhibitors and increased risk of lung cancer. Research indicates that the ACE inhibitors can increase the buildup of the chemicals bradykinin and substance P, both of which are found on lung cancer tissue.

Studies have suggested that diuretics may contribute to an increased risk of renal cell carcinoma, particularly in women. Diuretics have also been linked to increased incidences of breast cancer in women.

Related Articles

  • Propecia


    In 1997, the FDA approved Propecia for the treatment of male pattern baldness. Its manufacturer, Merck & Co., is a multinational pharmaceutical company that has marketed Propec Read More...

  • Onglyza


    Onglyza was co-formulated by Bristol-Myers Squibb and AstraZeneca in 2007. On July 31, 2009, it was approved by the FDA for treatment of type-2 diabetes. Its key active ingredient, Read More...

  • Arava


    Arava is manufactured and sold by Sanofi-Aventis. Its underlying drug, leflunomide, is designed to manage the symptoms of rheumatoid arthritis. Arava was approved by the FDA in 199 Read More...

© 2015-2022 LawConnect, Inc. All rights reserved.